15/09/2020 - 07:46

PharmAust sets strategy for multipurpose drug

15/09/2020 - 07:46

Bookmark

Save articles for future reference.

Perth based oncology company, PharmAust, has confirmed the anti-viral potential of its Monepantel drug in the fight against COVID-19 and firmed up its strategy for other potential treatments using the drug, including treating cancer in dogs and treating human neurodegenerative disease.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options